Ignite Creation Date:
2024-05-06 @ 8:17 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06323655
Status:
COMPLETED
Last Update Posted:
2024-03-21
First Post:
2019-10-18
Brief Title:
Evaluation of Next-Day Residual Effects of Tasimelteon Compared With Placebo and Active Control in Healthy Subjects
Sponsor:
Vanda Pharmaceuticals
Organization:
Vanda Pharmaceuticals
Organization Data
Organization:
Vanda Pharmaceuticals
Class:
INDUSTRY
Study ID:
VP-VEC-162-1201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Vanda Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None